{"id":"W4410943999","doi":"10.1056/nejmoa2502931","title":"Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer","year":2025,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Oncology; Chemotherapy; Neoadjuvant therapy; Internal medicine; Lung cancer; Cancer; Immunotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007055432,0.0001723199,0.0006696536,0.0003232476,0.00002894848,0.000008251043,0.0001205644,0.00007162018,0.0005296782],"category_scores_gemma":[0.00005294125,0.0001007489,0.00007524068,0.0003668982,0.0001052791,0.00007157133,0.00000877726,0.0003989623,3.172139e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003562473,"about_ca_system_score_gemma":0.001002692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001959011,"about_ca_topic_score_gemma":0.0008567018,"domain_scores_codex":[0.9986057,0.00005441123,0.0005331301,0.0001477261,0.0004339598,0.0002250544],"domain_scores_gemma":[0.9992065,0.0001091702,0.000225712,0.0001696114,0.0001481437,0.0001408328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09711865,0.0002303185,0.1872965,0.0003488389,0.001461044,0.001002347,0.00378074,0.0001896966,0.01826952,0.0001921941,0.05581637,0.6342938],"study_design_scores_gemma":[0.5192209,0.00323465,0.2417153,0.007809139,0.0004516485,0.0008024131,0.0004848949,0.0005086955,0.001306407,0.0002024198,0.2240072,0.0002564032],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9070008,0.02377729,0.001059653,0.06229205,0.001395306,0.0003068478,0.000001786195,0.00001491323,0.004151344],"genre_scores_gemma":[0.9810506,0.007251556,0.0002803417,0.004395116,0.002315144,0.000003259614,0.000003019553,0.00002216125,0.004678872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6340374,"threshold_uncertainty_score":0.5799605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01091992738661193,"score_gpt":0.2999416408862375,"score_spread":0.2890217134996256,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}